Martin Auster
Stock Analyst at Raymond James
(4.54)
# 1,016
Out of 4,609 analysts
208
Total ratings
50.5%
Success rate
15.9%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Maintained: Buy | $35 → $40 | $25.88 | +54.56% | 4 | Aug 4, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $468 → $420 | $216.12 | +94.34% | 5 | Jul 31, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintained: Buy | $28 → $21 | $8.39 | +150.30% | 2 | Jul 31, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $5 | $1.39 | +259.71% | 1 | Jun 8, 2026 | |
| SEPN Septerna | Maintained: Buy | $38 → $53 | $39.53 | +34.08% | 2 | Jun 8, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $46 → $66 | $44.42 | +48.58% | 4 | Jun 1, 2026 | |
| EQ Equillium | Maintained: Buy | $6 → $7 | $2.12 | +230.19% | 2 | May 28, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $76 → $81 | $30.22 | +168.03% | 2 | May 26, 2026 | |
| BBIO BridgeBio Pharma | Downgraded: Hold | n/a | $82.80 | - | 4 | May 26, 2026 | |
| SYRE Spyre Therapeutics | Initiated Coverage: Buy | $80 | $103.42 | -22.65% | 1 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $60 | $52.64 | +13.98% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $56 | $28.53 | +96.28% | 2 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $13.38 | +198.95% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $6.02 | +331.89% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $117 | $77.44 | +51.08% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $271 | $249.85 | +8.47% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $81.37 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $6 | $46.42 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 → $100 | $61.46 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.77 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $8.71 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $12 | $29.88 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $58 | $31.93 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $156 → $72 | $16.78 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $169 → $196 | $532.94 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $98 | $2.11 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $99 | $25.82 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $132.55 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $54 | $70.85 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 → $78 | $45.36 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $12 | $4.26 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $11.24 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $43 | $9.28 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $521.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $14 | $29.54 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.56 | n/a | 4 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $54.77 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.000001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.7471 | n/a | 1 | Jan 18, 2018 |
Dyne Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $25.88
Upside: +54.56%
Alnylam Pharmaceuticals
Jul 31, 2026
Maintained: Buy
Price Target: $468 → $420
Current: $216.12
Upside: +94.34%
Phathom Pharmaceuticals
Jul 31, 2026
Maintained: Buy
Price Target: $28 → $21
Current: $8.39
Upside: +150.30%
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.39
Upside: +259.71%
Septerna
Jun 8, 2026
Maintained: Buy
Price Target: $38 → $53
Current: $39.53
Upside: +34.08%
Edgewise Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $46 → $66
Current: $44.42
Upside: +48.58%
Equillium
May 28, 2026
Maintained: Buy
Price Target: $6 → $7
Current: $2.12
Upside: +230.19%
Tectonic Therapeutic
May 26, 2026
Maintained: Buy
Price Target: $76 → $81
Current: $30.22
Upside: +168.03%
BridgeBio Pharma
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $82.80
Upside: -
Spyre Therapeutics
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $103.42
Upside: -22.65%
Mar 30, 2026
Reiterated: Buy
Price Target: $53 → $60
Current: $52.64
Upside: +13.98%
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $28.53
Upside: +96.28%
Jan 26, 2026
Reiterated: Buy
Price Target: $40
Current: $13.38
Upside: +198.95%
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $6.02
Upside: +331.89%
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $77.44
Upside: +51.08%
Oct 17, 2025
Initiated Coverage: Buy
Price Target: $271
Current: $249.85
Upside: +8.47%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $81.37
Upside: n/a
Nov 16, 2021
Maintained: Buy
Price Target: $26 → $6
Current: $46.42
Upside: n/a
Oct 28, 2021
Maintained: Buy
Price Target: $102 → $100
Current: $61.46
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.77
Upside: n/a
Mar 16, 2021
Maintained: Hold
Price Target: $7 → $8
Current: $8.71
Upside: n/a
Mar 16, 2021
Maintained: Buy
Price Target: $29 → $12
Current: $29.88
Upside: n/a
Mar 10, 2021
Maintained: Buy
Price Target: $49 → $58
Current: $31.93
Upside: n/a
Mar 2, 2021
Maintained: Hold
Price Target: $156 → $72
Current: $16.78
Upside: n/a
Feb 22, 2021
Maintained: Buy
Price Target: $169 → $196
Current: $532.94
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $62 → $98
Current: $2.11
Upside: n/a
Jan 25, 2021
Maintained: Hold
Price Target: $64 → $99
Current: $25.82
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $132.55
Upside: n/a
Jan 11, 2021
Maintained: Hold
Price Target: $53 → $54
Current: $70.85
Upside: n/a
Nov 20, 2020
Maintained: Buy
Price Target: $76 → $78
Current: $45.36
Upside: n/a
Nov 6, 2020
Maintained: Hold
Price Target: $11 → $12
Current: $4.26
Upside: n/a
Nov 5, 2020
Maintained: Hold
Price Target: $21 → $24
Current: $11.24
Upside: n/a
Oct 8, 2020
Maintained: Buy
Price Target: $27 → $43
Current: $9.28
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $521.00
Upside: n/a
Sep 15, 2020
Maintained: Sell
Price Target: $14
Current: $29.54
Upside: n/a
Aug 3, 2020
Maintained: Hold
Price Target: $5
Current: $3.56
Upside: n/a
Jul 7, 2020
Maintained: Hold
Price Target: $16
Current: $54.77
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.000001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $0.7471
Upside: n/a